U.S., Sept. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07183384) titled 'MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction' on Sept. 02.
Brief Summary: ---
Why Is This Study Being Done?
Women who have preeclampsia during pregnancy face a much higher risk of heart disease later in life. Preeclampsia is a serious pregnancy condition that causes high blood pressure and damages blood vessels. Even after the baby is born, the blood vessels do not fully heal on their own, which can lead to heart problems/cardiovascular years later.
This study tests whether a new treatment called exosomes can help repair damaged blood vessels in women who had preeclampsia. Exosomes are tiny particles that co...